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Summary
Background: Previous studies have reported diffuse destabilization of atherosclerotic plaques
in acute myocardial infarction (AMI). We used intravascular ultrasound (IVUS) to assess coronary
culprit lesions in ST segment elevation MI (STEMI) vs. in non-ST segment elevation MI (NSTEMI).
Methods: Patient population comprised 125 STEMI and 185 NSTEMI patients. IVUS ﬁndings
included ruptured plaque (a cavity that communicated with the lumen with an overlying resid-
ual ﬁbrous cap fragment), lipid-pool like image (a pooling of hypoechoic or echolucent material
covered with a hyperechoic layer), thrombus (discrete intraluminal ﬁlling defects), and plaque
prolapse (tissue extrusion through the stent strut at post-stenting).
Results: Culprit lesions had larger external elastic membrane area (13.5± 4.9mm2 vs.
11.9± 4.3mm2, p = 0.002), larger plaque plus media area (10.8± 4.4mm2 vs. 9.1± 4.1mm2,
p = 0.001), and greater plaque burden (78.7± 10.1% vs. 74.8± 12.0%, p = 0.002), and smaller
culprit lesion site calcium arc (96± 90◦ vs. 153± 114◦, p = 0.002) in patients with STEMI than
in those with NSTEMI. Culprit lesion plaque ruptures, lipid-pool like images, and thrombus
were observed more frequently in patients with STEMI than in those with NSTEMI (46% vs. 29%,
p = 0.002; 39% vs. 25%, p = 0.010; and 34% vs. 21%, p = 0.006, respectively). Culprit lesions were
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more predominantly hypoechoic in patients with STEMI than in those with NSTEMI (62% vs. 40%,
p < 0.001). There was a trend that post-stenting plaque prolapse was observed more frequently
in patients with STEMI than in those with NSTEMI (33% vs. 24%, p = 0.081).
Conclusions: Culprit lesions in STEMI have more markers of plaque instability (more plaque
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for Acquisition, Measurement and Reporting of Intravas-
cular Ultrasound Studies [13]. External elastic membrane
(EEM) and lumen cross-sectional areas (CSAs) were mea-rupture and thrombus, and la
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revious studies have demonstrated that rupture of a
ulnerable plaque and subsequent thrombus formation is
he most important mechanism leading to the devel-
pment of an acute myocardial infarction (AMI) [1,2].
ypical intravascular ultrasound (IVUS) features of AMI
nclude positive remodeling, plaque rupture, thrombus, and
ither spotty or deep calcium within the minimum lumen
ite [3—11].
To date, data on the differences of IVUS plaque char-
cteristics and post-procedural IVUS ﬁndings between ST
egment elevation MI (STEMI) and non-ST segment eleva-
ion MI (NSTEMI) are lacking. Therefore, we assessed the
ifferences of pre- and post-procedural IVUS ﬁndings using
rey-scale IVUS between patients with STEMI and those with
STEMI.
ethods
tudy population
VUS ﬁndings of a total of 310 patients with a ﬁrst AMI
125 STEMI and 185 NSTEMI) who underwent pre-intervention
VUS within 24 h from symptom onset, were stented suc-
essfully, and had post-intervention IVUS imaging were
nalyzed in the present study. We excluded patients with
rior MI, stent thrombosis, in-stent restenosis lesion, coro-
ary artery bypass graft failure, severe heart failure or
ardiogenic shock, patients studied with IVUS more than
4 h after symptom onset, and patients in whom ade-
uate IVUS images could not be obtained. All 310 infarct
esions were treated with stent implantation: 187 with drug-
luting stents [138 with sirolimus-eluting stents (Cypher
tent, Cordis, Johnson and Johnson, Miami Lakes, FL, USA)
nd 49 with paclitaxel-eluting stents (Taxus Stent, Boston
cientiﬁc, Boston, MA, USA)], and 123 with bare metal
tents.
The presence of STEMI was determined by >30min
f continuous chest pain, a new ST segment elevation
2mm on at least two contiguous electrocardiographic
eads, and creatine kinase-MB > 3 times normal. The pres-
nce of NSTEMI was diagnosed by chest pain and a
ositive cardiac biochemical marker without new ST seg-
ent elevation. Infarct-related arteries were identiﬁed
sing a combination of electrocardiographic ﬁndings, left
entricular wall motion abnormalities on left ventricu-
ar angiogram or two-dimensional echocardiogram, and
oronary angiogram. The protocol was approved by the
nstitutional Review Board. Hospital records of patients
ere reviewed to obtain information on clinical demo-
raphics.
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eplaque mass) compared with lesions in NSTEMI.
ology. Published by Elsevier Ireland Ltd. All rights reserved.
aboratory analysis
he blood samples were centrifuged, and serum was
emoved and stored at −70 ◦C until the assay could be
erformed. Venous blood samples were obtained before
tenting and within 24 h after stenting for the measurement
f absolute creatine kinase-MB and cardiac-speciﬁc troponin
levels. Absolute creatine kinase-MB levels were determined
y radioimmunoassay (Dade-Behring Inc., Miami, FL, USA).
ardiac-speciﬁc troponin I levels were measured by a param-
gnetic particle, chemiluminescent immunoenzymatic assay
Beckman, Coulter Inc., Fullerton, CA, USA). The serum
evels of total cholesterol, triglyceride, low-density lipopro-
ein cholesterol, and high-density lipoprotein cholesterol
ere measured by standard enzymatic methods. High-
ensitivity C-reactive protein was analyzed turbidimetrically
ith sheep antibodies against human C-reactive protein; this
as been validated against the Dade-Behring method [12].
uantitative coronary angiography (QCA) analysis
oronary angiogram was analyzed with validated QCA sys-
em (Philips H5000 or Allura DCI program, Philips Medical
ystems, Eindhoven, the Netherlands). With the outer
iameter of the contrast-ﬁlled catheter as the calibration
tandard, the minimal lumen diameter and reference diam-
ter were measured in diastolic frames from orthogonal
rojections.
VUS imaging and analysis
ll IVUS examinations were performed before and after
tenting after intracoronary administration of 300g nitro-
lycerin using a commercially available IVUS system (Boston
cientiﬁc Corporation/SCIMed, Minneapolis, MN, USA).
hen the initial TIMI ﬂow grade was less than 2, we used
he aspiration catheter or the small-sized balloon to open
he occluded artery and to minimize thrombus at the cul-
rit lesion before we put the IVUS catheter. The IVUS
atheter was advanced distal to the target lesion, and imag-
ng was performed retrograde to the aorto-ostial junction
t an automatic pullback speed of 0.5mm/s. IVUS analysis
as performed according to the American College of Car-
iology Clinical Expert Consensus Document on Standardsured. Plaque plus media (P&M) CSA was calculated as EEM
inus lumen CSA; and plaque burden was calculated as
&M divided by EEM CSA. Proximal and distal references
ere the single slices with the largest lumen and small-
st plaque CSAs within 10mm proximally and distally, but
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before any large side branch. The lesion was the site with
the smallest lumen CSA; if there were multiple image slices
with the same minimum lumen CSA, then the image slice
with the largest EEM and P&M was measured. Hypoechoic
plaque was less bright compared with the reference adven-
titia. Hyperechoic, noncalciﬁed plaque was as bright as
or brighter than the reference adventitia without acoustic
shadowing. Calcium plaque was hyperechoic with shadow-
ing. A calciﬁed lesion contained >90◦ of circumferential
lesion calcium. When there was no dominant plaque compo-
sition, the plaque was classiﬁed as mixed. Coronary artery
remodeling was assessed by comparing the lesion site to
the reference EEM CSA. Remodeling index was the lesion
site EEM CSA divided by the average of the proximal and
distal reference EEM CSA. Positive remodeling was deﬁned
as a remodeling index >1.05, intermediate remodeling as
a remodeling index between 0.95 and 1.05, and negative
remodeling as a remodeling index <0.95 [14]. A ruptured
plaque contained a cavity that communicated with the
lumen with an overlying residual ﬁbrous cap fragment. A
fragmented and loosely adherent plaque without a distinct
cavity and without a ﬁbrous cap fragment was not con-
sidered a plaque rupture. Rupture sites separated by a
length of artery containing smooth lumen contours with-
out cavities were considered to represent different plaque
ruptures [15,16]. Plaque cavity was measured and extrap-
olated to the ruptured capsule area. Thrombus was an
intraluminal mass having a layered or lobulated appear-
ance, evidence of blood ﬂow (microchannels) within the
mass, and speckling or scintillation [16,17]. A lipid-pool like
image was deﬁned as a pooling of hypoechoic or echolucent
material covered with a hyperechoic layer. Plaque prolapse
was deﬁned as tissue extrusion through the stent strut at
post-intervention.
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Table 1 Baseline characteristics.
STEMI (n =
Age (years) 65± 13
Male gender 72 (58%)
Diabetes mellitus 41 (33%)
Hypertension 87 (70%)
Smoking 51 (41%)
Dyslipidemia 79 (63%)
Family history of coronary artery disease 27 (22%)
Ejection fraction (%) 44± 12
Creatin kinase-MB (U/l) 38.8± 85.
Cardiac-speciﬁc troponin I (ng/ml) 27.7± 59.
White blood cells (103 mm−3) 9.2± 4.1
Hemoglobin (g/dl) 12.3± 1.9
Platelet count (103 mm−3) 229± 98
Creatinine clearance (ml/min) 60± 34
Total cholesterol (mg/dl) 173± 48
Triglyceride (mg/dl) 138± 80
LDL cholesterol (mg/dl) 105± 38
HDL cholesterol (mg/dl) 44± 12
hs-CRP (mg/dl) 2.6± 4.0
STEMI, ST segment elevation myocardial infarction; NSTEMI, non-ST se
tein; HDL, high-density lipoprotein; CRP, C-reactive protein.17
tatistical analysis
he statistical Package for Social Sciences (SPSS) for Win-
ows, version 15.0 (Chicago, IL, USA) was used for all
nalyses. Continuous variables were presented as the mean
alue± 1SD; comparisons were conducted by Student’s t-
est or nonparametric Wilcoxon test if normality assumption
as violated. Discrete variables were presented as percent-
ges and relative frequencies; comparisons were conducted
y chi-square statistics or Fisher’s exact test as appropri-
te. Multiple logistic regression analysis was performed to
dentify independent predictors of post-stenting creatine
inase-MB elevation. A p-value <0.05 was considered sta-
istically signiﬁcant.
esults
atient characteristics
he baseline characteristics are summarized in Table 1.
here were no signiﬁcant differences in age, gender, risk
actors for coronary artery disease, and ejection fraction
etween patients with STEMI and those with NSTEMI. Base-
ine creatine kinase-MB and cardiac-speciﬁc troponin I levels
ere more signiﬁcantly elevated, and creatinine clearance
as signiﬁcantly lower in patients with STEMI compared with
hose with NSTEMI.ngiographic and procedural results
ngiographic ﬁndings and procedural results are summa-
ized in Table 2. There were no signiﬁcant differences in
nfarct-related artery, lesion location, incidence of mul-
125) NSTEMI (n = 185) p-Value
67± 11 0.3
107 (58%) 1.0
70 (38%) 0.4
131 (71%) 0.8
70 (38%) 0.5
127 (69%) 0.3
25 (14%) 0.062
44± 13 1.0
9 12.9± 35.2 0.002
5 6.7± 23.1 <0.001
9.0± 3.1 0.7
12.3± 2.3 0.8
227± 80 0.9
70± 34 0.006
166± 41 0.3
121± 52 0.093
101± 39 0.4
42± 14 0.5
1.8± 4.5 0.2
gment elevation myocardial infarction; LDL, low-density lipopro-
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Table 2 Coronary angiographic ﬁndings and procedural results.
STEMI (n = 125) NSTEMI (n = 185) p-Value
Infarct-related artery 0.055
Left main 2 (2%) 3 (2%)
LAD 70 (56%) 97 (52%)
LCX 9 (7%) 33 (18%)
RCA 44 (35%) 52 (28%)
Lesion location 0.3
Ostium 0 (0%) 4 (2%)
Proximal 46 (37%) 75 (41%)
Middle 68 (54%) 87 (47%)
Distal 11 (9%) 19 (10%)
Multivessel disease 54 (43%) 99 (54%) 0.13
TIMI ﬂow grade 0 27 (22%) 33 (18%) 0.4
Stent type 0.4
Sirolimus-eluting stent 51 (41%) 87 (47%)
Paclitaxel-eluting stent 27 (22%) 40 (22%)
Bare-metal stent 47 (37%) 58 (31%)
No. of deployed stents 1.18± 0.57 1.22± 0.39 0.3
Stent diameter (mm) 3.34± 0.51 3.19± 0.39 0.004
Stent length (mm) 25.0± 11.6 23.4± 10.3 0.19
Direct stenting 65 (52%) 113 (61%) 0.11
Inﬂation pressure (atm) 14.2± 2.6 14.6± 2.8 0.2
GPIIb/IIIa inhibitor use 31 (25%) 29 (16%) 0.046
Distal protection device use 11 (9%) 13 (7%) 0.6
Reference diameter (mm) 3.38± 0.94 3.26± 0.79 0.11
Pre-PCI MLD (mm) 0.60± 0.30 0.67± 0.54 0.4
Lesion length (mm) 22± 12 20± 10 0.2
T segment elevation myocardial infarction; LAD, left anterior descend-
y; TIMI, thrombolysis in myocardial infarction; GP, glycoprotein; PCI,
er.
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NSTEMI (Fig. 3). At post-intervention, there was a trend that
plaque prolapse was observed more frequently in patients
with STEMI compared with those with NSTEMI (33% vs. 24%,
p = 0.081).
Post-stenting cardiac enzyme elevation
Cardiac enzyme was elevated more signiﬁcantly after stent-
ing for culprit lesions in patients with STEMI compared withSTEMI, ST segment elevation myocardial infarction; NSTEMI, non-S
ing artery; LCX, left circumﬂex artery; RCA, right coronary arter
percutaneous coronary intervention; MLD, minimal lumen diamet
ivessel disease and TIMI ﬂow grade 0, stent type, and
ngiographic lesion length. However, stent diameter was sig-
iﬁcantly larger and glycoprotein IIb/IIIa inhibitor was used
ore frequently in patients with STEMI compared with those
ith NSTEMI.
VUS results
VUS ﬁndings are summarized in Table 3. Lesion sites EEM
SA, P&M CSA, and plaque burden were signiﬁcantly greater
n patients with STEMI compared with those with NSTEMI.
alcium arc was signiﬁcantly smaller and hypoechoic plaque
as observedmore frequently patients with STEMI compared
ith those with NSTEMI.
Plaque rupture was observed more frequently in patients
ith STEMI compared with those with NSTEMI (Fig. 1) and
here was a trend that multiple plaque ruptures were
bserved more frequently in patients with STEMI compared
ith those with NSTEMI (19% vs. 13%, p = 0.14). However,
laque cavity CSA and ruptured plaque length were not
ifferent between patients with STEMI and those with
STEMI (2.34± 1.16mm2 vs. 2.33± 1.58mm2, p = 0.9, and
.69± 1.11mm vs. 2.67± 1.67mm, p = 0.9, respectively).
VUS-detected thrombus was observed more frequently in
atients with STEMI compared with those with NSTEMI
Fig. 2). The presence of lipid-pool like image was more
ommon in patients with STEMI compared with those with
Figure 1 The incidence of plaque rupture in culprit lesions in
ST segment elevation myocardial infarction (STEMI) compared
with those in non-ST segment elevation myocardial infarction
(NSTEMI).
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Table 3 Intravascular ultrasound ﬁndings.
STEMI (n = 125) NSTEMI (n = 185) p-Value
Reference
EEM CSA (mm2) 13.4± 4.4 12.5± 4.8 0.085
Lumen CSA (mm2) 8.6± 3.0 8.1± 3.1 0.15
P&M CSA (mm2) 4.8± 2.5 4.4± 2.6 0.16
Plaque burden (%) 35± 11 34± 11 0.4
Lesion site
EEM CSA (mm2) 13.5± 4.9 11.9± 4.3 0.002
Lumen CSA (mm2) 2.6± 1.2 2.8± 1.4 0.3
P&M CSA (mm2) 10.8± 4.4 9.1± 4.1 0.001
Plaque burden (%) 79± 10 75± 12 0.002
IVUS lesion length (mm) 18.4± 11.5 16.7± 7.5 0.17
Calcium arc (◦) 96± 90 153± 114 <0.001
Plaque morphology <0.001
Hypoechoic 77 (62%) 75 (41%)
Hyperechoic, noncalciﬁed 18 (14%) 34 (18%)
Hyperechoic, calciﬁed 14 (11%) 64 (35%)
Mixed 16 (13%) 12 (7%)
Remodeling index 1.02± 0.21 0.98± 0.22 0.17
Remodeling pattern 0.6
Positive 45 (36%) 68 (37%)
Intermediate 34 (27%) 41 (22%)
Negative 46 (37%) 76 (41%)
STEMI, ST segment elevation myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; EEM, external elastic
membrane; CSA, cross-sectional area; P&M, plaque plus media; IVUS, intravascular ultrasound.
those with NSTEMI [creatine kinase-MB; +14.1± 30.2U/l
vs. +8.9± 28.5 U/l, p = 0.032, and cardiac-speciﬁc
troponin I; +20.2± 50.1 ng/ml vs. +13.5± 29.2 ng/ml,
p = 0.020]. Multiple logistic regression analysis was per-
formed to determine independent predictors of post-
stenting creatine kinase-MB elevation. The following
variables were tested (all with p < 0.2 in univariate anal-
ysis): STEMI, creatinine clearance, TIMI ﬂow grade 0, stent
length, IVUS plaque burden, plaque rupture, thrombus, posi-
tive remodeling, and plaque prolapse. Plaque prolapse [odds
ratio (OR) = 7.03; 95% CI 3.34—13.08, p < 0.001], plaque rup-
Figure 2 The incidence of intravascular ultrasound-detected
thrombus in culprit lesions in ST segment elevation myocar-
dial infarction (STEMI) compared with those in non-ST segment
elevation myocardial infarction (NSTEMI).
Figure 3 The incidence of lipid-pool like image in culprit
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ompared with those in non-ST segment elevation myocardial
nfarction (NSTEMI).
ure (OR = 2.15; 95% CI 1.21—3.57, p = 0.020), and thrombus
OR = 1.98; 95% CI 1.18—3.24, p = 0.023) were independently
ssociated with post-stenting creatine kinase-MB elevation.
here was a trend that STEMI was associated more likely
ith post-stenting creatine kinase-MB elevation compared
ith NSTEMI (OR = 1.96; 95% CI 0.83—4.56, p = 0.091).iscussion
he present IVUS study demonstrated that patients with
TEMI had (1) greater lesion site plaque burden and less
2s
m
d
t
p
e
p
A
t
S
c
P
c
i
r
h
a
t
t
c
l
l
l
a
e
n
a
e
p
i
s
s
N
p
t
m
w
i
a
p
r
s
[
l
p
t
p
p
a
a
t
t
r
S
F
s
o
f
t
s
b
a
p
i
a
b
i
c
a
r
w
a
M
i
e
a
p
A
a
C
C
m
t
p
f
o
o
t
t
t
D
N
A
T
c
W
v
R0
evere calciﬁcation, (2) more lipid-pool like image and
ore hypoechoic plaque, (3) more plaque rupture and IVUS-
etected thrombus, (4) more lipid-pool like image, (5) trend
oward higher incidence of multiple plaque rupture and
ost-stenting plaque prolapse, and (6) more cardiac enzyme
levation after stent implantation for culprit lesions com-
ared with those with NSTEMI.
Several previous pathologic studies have suggested that
MI results from plaque rupture or erosion and subsequent
hrombosis formation to occlude coronary arteries [18,19].
everal IVUS studies have reported varying percentage of
ulprit lesion plaque rupture in patients with AMI [5—9].
laque ruptures tend to occur at a point where the ﬁbrous
ap is thinnest and most heavily inﬁltrated by macrophages
ndicating ongoing inﬂammation at the site of plaque dis-
uption [20]. In the present study, culprit lesions in STEMI
ad more plaque rupture, more IVUS-detected thrombus,
nd trend towards more multiple plaque ruptures than in
hose in NSTEMI. The results of the present study suggest
hat patients with STEMI have more plaque vulnerability
ompared with those with NSTEMI.
In the present study, there was a trend that plaque pro-
apse was observed more frequently after stenting for culprit
esions in STEMI compared with those in NSTEMI. Plaque pro-
apse is an intraluminal tissue protrusion through stent struts
nd this can be easily and frequently detected by IVUS. Sev-
ral IVUS characteristics like hypoechoic plaque rather than
on-hypoechoic plaque, smaller minimal lumen diameter,
larger plaque burden, plaque rupture, positive remod-
ling, and long stent length were associated with plaque
rolapse, and the risk of plaque prolapse was higher dur-
ng aggressive stenting procedure [21—23]. In the present
tudy, plaque prolapse was observed more frequently after
tenting for culprit lesions in STEMI compared with those in
STEMI. Because patients with STEMI have more vulnerable
laques like plaque rupture and thrombus, this may provide
he conditions for tissue protrusion through the stent struts
ore easily compared with patients with NSTEMI.
Cardiac enzyme elevation after stenting is associated
ith cardiac mortality, even after successful revascular-
zation [24—28]. Cardiac enzyme release after coronary
rtery intervention is related to severe stenosis with large
laque burden and unstable plaque morphometry (positive
emodeling and plaque rupture) [29,30], and more aggres-
ive stenting procedure [24,30—32] and plaque prolapse
21,23]. In the present study, stent implantation for culprit
esions with plaque rupture and thrombus, and post-stenting
laque prolapse were associated with cardiac enzyme eleva-
ion after stenting. Although STEMI was not an independent
redictor of post-stenting cardiac enzyme elevation com-
ared to NSTEMI, it might be important to use more potent
nti-platelet agents and anticoagulation therapies, and less
ggressive stenting procedure for patients with STEMI than
hose with NSTEMI when we perform coronary stent implan-
ation because culprit lesions in STEMI have more plaque
upture, more thrombus, and more plaque prolapse.tudy limitations
irst, the present study is a retrospective single-center
tudy, so, is subject to limitations inherent in this typeY.J. Hong et al.
f clinical investigation. Second, IVUS imaging was per-
ormed at the discretion of the individual operators leading
o potential selection bias. Third, volumetric IVUS analy-
is was not performed in the present study. Fourth, it may
e difﬁcult to differentiate between organized thrombus
nd plaque prolapse. It is possible that some cases with
laque prolapse actually had thrombus prolapse. Fifth, it
s probable that IVUS can underestimate plaque rupture
t the time of primary intervention in patients with AMI,
ecause IVUS cannot detect plaque rupture if the cavity
s ﬁlled with thrombus. Actually, even after the aspiration
atheter was used, thrombus at the culprit lesion cannot be
spirated completely. Sixth, there are methodologic issues
elated to the measurement of a single creatine kinase-MB
ithin 24 h after stent placement, rather than a methodical
nd protocol-driven sequence and timing of creatine kinase-
B measurements. This may signiﬁcantly compromise the
nterpretation of the creatine kinase-MB data. Seventh, we
xcluded patients with coronary artery bypass graft failure
nd severe heart failure or cardiogenic shock. Thus, the
resent study might not represent the whole spectrum of
MI patients. Finally, long-term clinical follow-up was not
vailable.
onclusions
ulprit lesions in infarct-related arteries in STEMI have more
arkers of plaque vulnerability (more plaque rupture and
hrombus, and larger plaque mass) and higher frequency of
laque prolapse compared with lesions in NSTEMI. There-
ore, more aggressive treatment strategies such as the use
f high clopidogrel loading or glycoprotein IIb/IIIa inhibitors
r more intensive anticoagulation or more aggressive use of
hrombus aspiration are needed when we perform percu-
aneous intervention in patients with STEMI compared with
hose with NSTEMI.
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